ARX and pancreatic adenocarcinoma: Our present survival analysis suggests that high ARX expression is favorable for PAAD patients, which might suggest a subtype-specific behavior that is worth investigation since pancreatic tumors arising from endocrine or epithelial portion have different properties58–60.